Why the study?
Thoracic impedance drops measured by ICDs have been reported to correlate with VT/VF, but the temporal association required assessment through longitudinal analysis of daily remote monitoring trends.
Does a decrease in thoracic impedance predict ventricular tachycardia/fibrillation episodes in patients with ICDs or CRT-Ds?
Does a decrease in thoracic impedance predict ventricular tachycardia/fibrillation episodes in patients with ICDs or CRT-Ds?
Thoracic impedance drops are associated with VT/VF episodes in ICD patients but not CRT-D patients, though their predictive utility is limited as drops often follow rather than precede arrhythmias.
TI drops associated with VT/VF risk in ICD but not CRT-D patients; hypothesis-generating, should not change practice without prospective validation.
INTRODUCTION: Thoracic impedance (TI) drops measured by implantable cardioverter-defibrillators (ICDs) have been reported to correlate with ventricular tachycardia/fibrillation (VT/VF). The aim of our study was to assess the temporal association of decreasing TI trends with VT/VF episodes through a longitudinal analysis of daily remote monitoring data from ICDs and cardiac resynchronization therapy defibrillators (CRT-Ds). METHODS AND RESULTS: Retrospective data from 2384 patients were randomized 1:1 into a derivation or validation cohort. The TI decrease rate was defined as the percentage of rolling weeks with a continuously decreasing TI trend. The derivation cohort was used to determine a TI decrease rate threshold for a ≥99% specificity of arrhythmia prediction. The associated risk of VT/VF episodes was estimated in the validation cohort by dividing the available follow-up into 60-day assessment intervals. Analyses were performed separately for 1354 ICD and 1030 CRT-D patients. During a median follow-up of 2.0 years, 727 patients (30.4%) experienced 3298 confirmed VT/VF episodes. In the ICD group, a TI decrease rate of >60% was associated with a higher risk of VT/VF episode in a 60-day assessment interval (stratified hazard ratio, 1.42; 95% confidence interval (CI), 1.05-1.92; p = .023). The TI decrease preceded (40.8%) or followed (59.2%) the VT/VF episodes. In the CRT-D group, no association between TI decrease and VT/VF episodes was observed (p = .84). CONCLUSION: In our longitudinal analysis, TI decrease was associated with VT/VF episodes only in ICD patients. Preventive interventions may be difficult since episodes can occur before or after TI decrease.
No takes yet. Share an insight, caveat, or question.
Rodio et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: